Ultivue Announces $50M Financing Round

30 Apr, 2021

Ultivue Announces $50M Financing Round
Photo by Ian Melton on Unsplash

– Ultivue announced the completion of a $50m Series D round of financing.
– New investors include Ally Bridge Group, Pura Vida Investments and Tao Capital Partners.
– Previous venture investors in Ultivue who also participated in the financing include ARCH Ventures, Northpond Ventures and Applied Ventures, LLC.
– This additional funding will help Ultivue strengthen its position in the market, deliver innovative solutions to address the dynamic nature of tumor biology from precious tissue samples and to provide researchers and pathologists with the ability to fully realize the potential of tissue biomarkers within digital pathology workflows.

Biopharma Biotechnology North America Pharmaceutical
Crunchbase icon

Content report

The following text will be sent to our editors: